New nasal spray for allergies passes first safety check
NCT ID NCT07345442
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested the safety and tolerability of a new corticosteroid nasal spray called PA9159 in 36 healthy Chinese adults. Participants received either a single dose or seven daily doses of the spray, or a placebo. The goal was to find the maximum safe dose and see how the drug moves through the body. This is a first step toward possibly treating allergic rhinitis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PA9159 (a novel corticosteroid) nasal spray
- What this could lead to
- If successful, this could lead to a new treatment option for allergic rhinitis symptoms.
- What could go wrong
- This is a very early Phase 1 safety study with only 36 healthy people, not patients. It does not test effectiveness, and the drug may not work or may have side effects in later trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Allergy study seeks to pinpoint those most bothered by cats and birch pollen
- Dog allergy vaccine shows promise in small swedish trial